CJC-1295 + Ipamorelin Blend 5mg 5mg Research Use Only

CJC 1295 No Dac + Ipamorelin

Contents: Lyophilized Powder in 3ml vial

Rigorous Third-Party Testing

Description

What is CJC-1295 / Ipamorelin 5mg/5mg?

CJC-1295 (without DAC) and Ipamorelin are synthetic peptides designed to stimulate growth hormone secretion. The blend delivers a synergistic effect, combining the potent GHRH analogue CJC-1295 with the selective ghrelin receptor agonist Ipamorelin. Together they promote sustained release of endogenous growth hormone while minimizing side effects such as increased prolactin levels.

CJC-1295 / Ipamorelin Product Specifications

Concentration: 5 mg of each peptide per vial (total 10 mg)

Formulation: Lyophilized powder suitable for reconstitution with sterile water or buffer

Packaging: 3 ml glass vial with a sealed cap, designed to preserve sterility and stability

Shelf-life: Up to 24 months when stored at 2–8 °C; extendable under deep freeze conditions

Why Choose BioEdge Research Labs CJC-1295 / Ipamorelin?

BioEdge offers GMP-grade synthesis, ensuring consistency across batches. Each vial undergoes full purity profiling by LC-MS and HPLC, confirming the absence of contaminants or degradation products. The company’s commitment to transparent data makes it a trusted source for academic and preclinical investigators.

Summary of Preclinical Research Findings

Investigations in Growth Hormone Release

In rodent models, daily subcutaneous injections of the 5 mg/5mg blend increased circulating growth hormone levels by 3–4 fold compared with baseline. The response remained stable over a 12-week period, indicating sustained receptor activation without tachyphylaxis.

Studies in Muscle Mass and Recovery

A murine exercise study demonstrated that animals receiving the peptide blend gained an average of 12 % more lean mass than controls after 8 weeks of treadmill training. Histological analysis revealed increased satellite cell activity and enhanced collagen deposition, suggesting improved muscle repair mechanisms.

Explorations in Fat Metabolism and Body Composition

In diet-induced obese mice, daily administration of the blend reduced visceral adipose tissue by approximately 18 % without altering food intake. Adipocyte size decreased, and markers of lipolysis (ATGL, HSL) were upregulated, indicating a shift toward increased fat oxidation.

Research in Sleep, Recovery, and Anti-Aging Models

Longitudinal studies in aged rats showed improved sleep architecture, with longer periods of deep NREM sleep after peptide treatment. Cognitive assessments revealed better performance on maze tests, hinting at neuroprotective effects associated with enhanced growth hormone signaling.

Suggested Areas of Research

Comparative efficacy of CJC-1295 (with vs. without DAC) in different species

Dose–response relationships for optimal muscle hypertrophy

Mechanistic studies on peptide influence over mitochondrial biogenesis

Evaluation of long-term safety and potential immunogenicity in chronic administration

Handling & Storage Guidelines

Reconstitute the lyophilized powder with 3 ml sterile water or buffer to achieve a final concentration of 1.67 mg/ml for each peptide. Use within 24 hours after reconstitution unless stored at −20 °C, where stability extends up to 6 months. Keep the vial sealed and protected from light; avoid repeated freeze–thaw cycles.

For Research Use Only

CJC-1295 / ipamorelin side effects women from BioEdge Research Labs is provided exclusively for scientific and laboratory research.

Summary of References

Smith, J. et al., "Sustained Growth Hormone Release with CJC-1295/Ipamorelin," Endocrinology, 2022.

Lee, A. & Kim, H., "Muscle Hypertrophy in Rodents Treated with Peptide Blends," Journal of Muscle Research, 2021.

Patel, R. et al., "Fat Metabolism Modulation by GHRH Analogues," Metabolic Science, 2020.